These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
574 related items for PubMed ID: 11520076
1. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Zennadi R, Abdel-Wahab Z, Seigler HF, Darrow TL. Cell Immunol; 2001 Jun 15; 210(2):96-105. PubMed ID: 11520076 [Abstract] [Full Text] [Related]
2. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15. Takahashi T, Chapman PB, Yang SY, Hara I, Vijayasaradhi S, Houghton AN. J Immunol; 1995 Jan 15; 154(2):772-9. PubMed ID: 7814883 [Abstract] [Full Text] [Related]
3. Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity. Abdel-Wahab ZA, Osanto S, Darrow TL, Barber JR, Vervaert CE, Gangavalli R, McCallister TJ, Seigler HF. Cancer Gene Ther; 1994 Sep 15; 1(3):171-9. PubMed ID: 7621248 [Abstract] [Full Text] [Related]
4. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes. Ogasawara M, Rosenberg SA. Cancer Res; 1993 Aug 01; 53(15):3561-8. PubMed ID: 8101762 [Abstract] [Full Text] [Related]
5. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens. Darrow TL, Slingluff CL, Seigler HF. J Immunol; 1989 May 01; 142(9):3329-35. PubMed ID: 2785141 [Abstract] [Full Text] [Related]
6. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. Guerry D, Alexander MA, Elder DE, Herlyn MF. J Immunol; 1987 Jul 01; 139(1):305-12. PubMed ID: 3108402 [Abstract] [Full Text] [Related]
7. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL. Cancer Res; 1991 Nov 15; 51(22):6153-62. PubMed ID: 1718596 [Abstract] [Full Text] [Related]
8. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis. Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT. Clin Cancer Res; 1996 Jan 15; 2(1):87-95. PubMed ID: 9816095 [Abstract] [Full Text] [Related]
9. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. Hom SS, Topalian SL, Simonis T, Mancini M, Rosenberg SA. J Immunother (1991); 1991 Jun 15; 10(3):153-64. PubMed ID: 1868040 [Abstract] [Full Text] [Related]
10. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Pandolfi F, Boyle LA, Trentin L, Kurnick JT, Isselbacher KJ, Gattoni-Celli S. Cancer Res; 1991 Jun 15; 51(12):3164-70. PubMed ID: 1904004 [Abstract] [Full Text] [Related]
11. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. Yang TH, Aosai F, Norose K, Ueda M, Yano A. J Immunol; 1995 Jan 01; 154(1):290-8. PubMed ID: 7995948 [Abstract] [Full Text] [Related]
12. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro. Guilloux Y, Viret C, Gervois N, Le Dréan E, Pandolfino MC, Diez E, Jotereau F. Eur J Immunol; 1994 Sep 01; 24(9):1966-73. PubMed ID: 7522155 [Abstract] [Full Text] [Related]
13. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer. Yoshino I, Peoples GE, Goedegebuure PS, Maziarz R, Eberlein TJ. J Immunol; 1994 Mar 01; 152(5):2393-400. PubMed ID: 8133050 [Abstract] [Full Text] [Related]
14. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. Crowley NJ, Darrow TL, Quinn-Allen MA, Seigler HF. J Immunol; 1991 Mar 01; 146(5):1692-9. PubMed ID: 1671580 [Abstract] [Full Text] [Related]
15. Classification of CD4+ T helper cell clones in human melanoma. Goedegebuure PS, Lee KY, Matory YL, Peoples GE, Yoshino I, Eberlein TJ. Cell Immunol; 1994 Jun 01; 156(1):170-9. PubMed ID: 7911074 [Abstract] [Full Text] [Related]
16. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE, Spits H. J Immunol; 1984 Jan 01; 132(1):510-9. PubMed ID: 6197458 [Abstract] [Full Text] [Related]
17. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas. Crowley NJ, Slingluff CL, Darrow TL, Seigler HF. Cancer Res; 1990 Feb 01; 50(3):492-8. PubMed ID: 2404572 [Abstract] [Full Text] [Related]
18. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. J Immunol; 1992 Jan 15; 148(2):638-43. PubMed ID: 1729379 [Abstract] [Full Text] [Related]
19. Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens. Heike M, Schlaak J, Schulze-Bergkamen H, Heyl S, Herr W, Schmitt U, Schneider PM, Meyer zum Büschenfelde KH. J Immunol; 1996 Mar 15; 156(6):2205-13. PubMed ID: 8690910 [Abstract] [Full Text] [Related]
20. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG, Turcovski-Corrales SM, Taub DD. J Immunother; 1998 Mar 15; 21(2):95-108. PubMed ID: 9551360 [Abstract] [Full Text] [Related] Page: [Next] [New Search]